AEON Biopharma, Inc. announced the approval of a 1-for-72 reverse stock split by its Board of Directors to comply with NYSE American listing requirements. This split will take effect on February 26, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback